eF-site ID 1lvc-ABCDEF
PDB Code 1lvc
Chain A, B, C, D, E, F

click to enlarge
Title Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin and 2' deoxy, 3' anthraniloyl ATP
Classification LYASE
Compound calmodulin-sensitive adenylate cyclase
Source (CALM_HUMAN)
Sequence A:  RIDVLKGEKALKASGLVPEHADAFKKIARELNTYILFRPV
NKLATNLIKSGVATKGLNVHGKSSDWGPVAGYIPFDQDLS
KKHGQQLAVEKGNLENKKSITEHEGEIGKIPLKLDHLRIE
ELKENGIILKGKKEIDNGKKYYLLESNNQVYEFRISDENN
EVQYKTKEGKITVLGEKFNWRNIEVMAKNVEGVLKPLTAD
YDLFALAPSLTEIKKQIPQKEWDKVVNTPNSLEKQKGVTN
LLIKYGIERKPDSTKGTLSNWQKQMLDRLNEAVKYTGYTG
GDVVNHGTEQDNEEFPEKDNEIFIINPEGEFILTKNWEMT
GRFIEKNITGKDYLYYFNRSYNKIAPGNKAYIEWTDPITK
AKINTIPTSAEFIKNLSSIRRSSSVKKIAGYLSDYYNSAN
HIFSQEKKRKISIFRGIQAYNEIENVLKSKQIAPEYKNYF
QYLKERITNQVQLLLTHQKFKLLYKQLNFTENETDNFEVF
QKIID
B:  DVLKGEKALKASGLVPEHADAFKKIARELNTYILFRPVNK
LATNLIKSGVATKGLNVHGKSSDWGPVAGYIPFDQDLSKK
HGQQLAVEKGNLENKKSITEHEGEIGKIPLKLDHLRIEEL
KENGIILKGKKEIDNGKKYYLLESNNQVYEFRISDENNEV
QYKTKEGKITVLGEKFNWRNIEVMAKNVEGVLKPLTADYD
LFALAPSLTEIKKQIPQKEWDKVVNTPNEKQKGVTNLLIK
YGIERKPDSTKGTLSNWQKQMLDRLNEAVKYTGYTGGDVV
NHGTEQDNEEFPEKDNEIFIINPEGEFILTKNWEMTGRFI
EKNITGKDYLYYFNRSYNKIAPGNKAYIEWTDPITKAKIN
TIPSVKKIAGYLSDYYNSANHIFSQEKKRKISIFRGIQAY
NEIENVLKSKQIAPEYKNYFQYLKERITNQVQLLLTHQKF
KLLYKQLNFTENETDNFEVFQKIID
C:  RIDVLKGEKALKASGLVPEHADAFKKIARELNTYILFRPV
NKLATNLIKSGVATKGLNVHGKSSDWGPVAGYIPFDQDLS
KKHGQQLAVEKGNLENKKSITEHEGEIGKIPLKLDHLRIE
ELKENGIILKGKKEIDNGKKYYLLESNNQVYEFRISDENN
EVQYKTKEGKITVLGEKFNWRNIEVMAKNVEGVLKPLTAD
YDLFALAPSLTEIKKQIPQKEWDKVVNTPNSLEKQKGVTN
LLIKYGIERKPDSTKGTLSNWQKQMLDRLNEAVKYTGYTG
GDVVNHGTEQDNEEFPEKDNEIFIINPEGEFILTKNWEMT
GRFIEKNITGKDYLYYFNRSYNKIAPGNKAYIEWTDPITK
AKINTIPTSAEFIKNLSSIRRSSNVGVYKDSGDKDEFAKK
ESVKKIAGYLSDYYNSANHIFSQEKKRKISIFRGIQAYNE
IENVLKSKQIAPEYKNYFQYLKERITNQVQLLLTHQKFKL
LYKQLNFTENETDNFEVFQKIID
D:  TEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPT
EAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEE
IREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEM
IREADIDGDGQVNYEEFVQMMTA
E:  TEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPT
EAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEE
IREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEM
IREADIDGDGQVNYEEFVQMMTA
F:  TEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPT
EAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEE
IREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEM
IREADIDGDGQVNYEEFVQMMTA
Description


Functional site

1) chain D
residue 129
type
sequence D
description BINDING SITE FOR RESIDUE CA D 800
source : AC1

2) chain D
residue 131
type
sequence D
description BINDING SITE FOR RESIDUE CA D 800
source : AC1

3) chain D
residue 133
type
sequence D
description BINDING SITE FOR RESIDUE CA D 800
source : AC1

4) chain D
residue 135
type
sequence Q
description BINDING SITE FOR RESIDUE CA D 800
source : AC1

5) chain D
residue 140
type
sequence E
description BINDING SITE FOR RESIDUE CA D 800
source : AC1

6) chain D
residue 93
type
sequence D
description BINDING SITE FOR RESIDUE CA D 801
source : AC2

7) chain D
residue 95
type
sequence D
description BINDING SITE FOR RESIDUE CA D 801
source : AC2

8) chain D
residue 97
type
sequence N
description BINDING SITE FOR RESIDUE CA D 801
source : AC2

9) chain D
residue 99
type
sequence Y
description BINDING SITE FOR RESIDUE CA D 801
source : AC2

10) chain D
residue 104
type
sequence E
description BINDING SITE FOR RESIDUE CA D 801
source : AC2

11) chain E
residue 129
type
sequence D
description BINDING SITE FOR RESIDUE CA E 802
source : AC3

12) chain E
residue 131
type
sequence D
description BINDING SITE FOR RESIDUE CA E 802
source : AC3

13) chain E
residue 133
type
sequence D
description BINDING SITE FOR RESIDUE CA E 802
source : AC3

14) chain E
residue 135
type
sequence Q
description BINDING SITE FOR RESIDUE CA E 802
source : AC3

15) chain E
residue 140
type
sequence E
description BINDING SITE FOR RESIDUE CA E 802
source : AC3

16) chain E
residue 93
type
sequence D
description BINDING SITE FOR RESIDUE CA E 803
source : AC4

17) chain E
residue 95
type
sequence D
description BINDING SITE FOR RESIDUE CA E 803
source : AC4

18) chain E
residue 97
type
sequence N
description BINDING SITE FOR RESIDUE CA E 803
source : AC4

19) chain E
residue 99
type
sequence Y
description BINDING SITE FOR RESIDUE CA E 803
source : AC4

20) chain E
residue 104
type
sequence E
description BINDING SITE FOR RESIDUE CA E 803
source : AC4

21) chain F
residue 129
type
sequence D
description BINDING SITE FOR RESIDUE CA F 804
source : AC5

22) chain F
residue 131
type
sequence D
description BINDING SITE FOR RESIDUE CA F 804
source : AC5

23) chain F
residue 133
type
sequence D
description BINDING SITE FOR RESIDUE CA F 804
source : AC5

24) chain F
residue 135
type
sequence Q
description BINDING SITE FOR RESIDUE CA F 804
source : AC5

25) chain F
residue 140
type
sequence E
description BINDING SITE FOR RESIDUE CA F 804
source : AC5

26) chain F
residue 93
type
sequence D
description BINDING SITE FOR RESIDUE CA F 805
source : AC6

27) chain F
residue 95
type
sequence D
description BINDING SITE FOR RESIDUE CA F 805
source : AC6

28) chain F
residue 97
type
sequence N
description BINDING SITE FOR RESIDUE CA F 805
source : AC6

29) chain F
residue 99
type
sequence Y
description BINDING SITE FOR RESIDUE CA F 805
source : AC6

30) chain F
residue 104
type
sequence E
description BINDING SITE FOR RESIDUE CA F 805
source : AC6

31) chain A
residue 491
type
sequence D
description BINDING SITE FOR RESIDUE YB A 901
source : AC7

32) chain A
residue 493
type
sequence D
description BINDING SITE FOR RESIDUE YB A 901
source : AC7

33) chain A
residue 577
type
sequence H
description BINDING SITE FOR RESIDUE YB A 901
source : AC7

34) chain B
residue 491
type
sequence D
description BINDING SITE FOR RESIDUE YB B 902
source : AC8

35) chain B
residue 493
type
sequence D
description BINDING SITE FOR RESIDUE YB B 902
source : AC8

36) chain B
residue 577
type
sequence H
description BINDING SITE FOR RESIDUE YB B 902
source : AC8

37) chain C
residue 491
type
sequence D
description BINDING SITE FOR RESIDUE YB C 903
source : AC9

38) chain C
residue 493
type
sequence D
description BINDING SITE FOR RESIDUE YB C 903
source : AC9

39) chain C
residue 577
type
sequence H
description BINDING SITE FOR RESIDUE YB C 903
source : AC9

40) chain A
residue 329
type
sequence R
description BINDING SITE FOR RESIDUE DOT A 999
source : BC1

41) chain A
residue 346
type
sequence K
description BINDING SITE FOR RESIDUE DOT A 999
source : BC1

42) chain A
residue 350
type
sequence V
description BINDING SITE FOR RESIDUE DOT A 999
source : BC1

43) chain A
residue 351
type
sequence H
description BINDING SITE FOR RESIDUE DOT A 999
source : BC1

44) chain A
residue 353
type
sequence K
description BINDING SITE FOR RESIDUE DOT A 999
source : BC1

45) chain A
residue 354
type
sequence S
description BINDING SITE FOR RESIDUE DOT A 999
source : BC1

46) chain A
residue 372
type
sequence K
description BINDING SITE FOR RESIDUE DOT A 999
source : BC1

47) chain A
residue 382
type
sequence K
description BINDING SITE FOR RESIDUE DOT A 999
source : BC1

48) chain A
residue 386
type
sequence E
description BINDING SITE FOR RESIDUE DOT A 999
source : BC1

49) chain A
residue 490
type
sequence A
description BINDING SITE FOR RESIDUE DOT A 999
source : BC1

50) chain A
residue 493
type
sequence D
description BINDING SITE FOR RESIDUE DOT A 999
source : BC1

51) chain A
residue 577
type
sequence H
description BINDING SITE FOR RESIDUE DOT A 999
source : BC1

52) chain A
residue 578
type
sequence G
description BINDING SITE FOR RESIDUE DOT A 999
source : BC1

53) chain A
residue 579
type
sequence T
description BINDING SITE FOR RESIDUE DOT A 999
source : BC1

54) chain A
residue 583
type
sequence N
description BINDING SITE FOR RESIDUE DOT A 999
source : BC1

55) chain A
residue 586
type
sequence F
description BINDING SITE FOR RESIDUE DOT A 999
source : BC1

56) chain C
residue 329
type
sequence R
description BINDING SITE FOR RESIDUE DOT C 1999
source : BC2

57) chain C
residue 346
type
sequence K
description BINDING SITE FOR RESIDUE DOT C 1999
source : BC2

58) chain C
residue 350
type
sequence V
description BINDING SITE FOR RESIDUE DOT C 1999
source : BC2

59) chain C
residue 351
type
sequence H
description BINDING SITE FOR RESIDUE DOT C 1999
source : BC2

60) chain C
residue 353
type
sequence K
description BINDING SITE FOR RESIDUE DOT C 1999
source : BC2

61) chain C
residue 354
type
sequence S
description BINDING SITE FOR RESIDUE DOT C 1999
source : BC2

62) chain C
residue 372
type
sequence K
description BINDING SITE FOR RESIDUE DOT C 1999
source : BC2

63) chain C
residue 386
type
sequence E
description BINDING SITE FOR RESIDUE DOT C 1999
source : BC2

64) chain C
residue 490
type
sequence A
description BINDING SITE FOR RESIDUE DOT C 1999
source : BC2

65) chain C
residue 493
type
sequence D
description BINDING SITE FOR RESIDUE DOT C 1999
source : BC2

66) chain C
residue 548
type
sequence T
description BINDING SITE FOR RESIDUE DOT C 1999
source : BC2

67) chain C
residue 577
type
sequence H
description BINDING SITE FOR RESIDUE DOT C 1999
source : BC2

68) chain C
residue 578
type
sequence G
description BINDING SITE FOR RESIDUE DOT C 1999
source : BC2

69) chain C
residue 579
type
sequence T
description BINDING SITE FOR RESIDUE DOT C 1999
source : BC2

70) chain C
residue 582
type
sequence D
description BINDING SITE FOR RESIDUE DOT C 1999
source : BC2

71) chain C
residue 583
type
sequence N
description BINDING SITE FOR RESIDUE DOT C 1999
source : BC2

72) chain C
residue 586
type
sequence F
description BINDING SITE FOR RESIDUE DOT C 1999
source : BC2

73) chain D
residue 20-32
type prosite
sequence DKDGDGTITTKEL
description EF_HAND_1 EF-hand calcium-binding domain. DKDGDGTITtkEL
source prosite : PS00018

74) chain D
residue 56-68
type prosite
sequence DADGNGTIDFPEF
description EF_HAND_1 EF-hand calcium-binding domain. DKDGDGTITtkEL
source prosite : PS00018

75) chain D
residue 93-105
type prosite
sequence DKDGNGYISAAEL
description EF_HAND_1 EF-hand calcium-binding domain. DKDGDGTITtkEL
source prosite : PS00018

76) chain D
residue 129-141
type prosite
sequence DIDGDGQVNYEEF
description EF_HAND_1 EF-hand calcium-binding domain. DKDGDGTITtkEL
source prosite : PS00018

77) chain D
residue 20
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

78) chain D
residue 67
type BINDING
sequence E
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

79) chain E
residue 20
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

80) chain E
residue 22
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

81) chain E
residue 24
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

82) chain E
residue 26
type BINDING
sequence T
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

83) chain E
residue 31
type BINDING
sequence E
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

84) chain E
residue 56
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

85) chain E
residue 58
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

86) chain E
residue 60
type BINDING
sequence N
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

87) chain E
residue 62
type BINDING
sequence T
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

88) chain D
residue 22
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

89) chain E
residue 67
type BINDING
sequence E
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

90) chain F
residue 20
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

91) chain F
residue 22
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

92) chain F
residue 24
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

93) chain F
residue 26
type BINDING
sequence T
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

94) chain F
residue 31
type BINDING
sequence E
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

95) chain F
residue 56
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

96) chain F
residue 58
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

97) chain F
residue 60
type BINDING
sequence N
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

98) chain F
residue 62
type BINDING
sequence T
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

99) chain D
residue 24
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

100) chain F
residue 67
type BINDING
sequence E
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

101) chain D
residue 26
type BINDING
sequence T
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

102) chain D
residue 31
type BINDING
sequence E
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

103) chain D
residue 56
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

104) chain D
residue 58
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

105) chain D
residue 60
type BINDING
sequence N
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

106) chain D
residue 62
type BINDING
sequence T
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI1

107) chain D
residue 101
type MOD_RES
sequence S
description Phosphoserine => ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569
source Swiss-Prot : SWS_FT_FI10

108) chain E
residue 101
type MOD_RES
sequence S
description Phosphoserine => ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569
source Swiss-Prot : SWS_FT_FI10

109) chain F
residue 101
type MOD_RES
sequence S
description Phosphoserine => ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569
source Swiss-Prot : SWS_FT_FI10

110) chain D
residue 110
type MOD_RES
sequence T
description Phosphothreonine => ECO:0007744|PubMed:24275569
source Swiss-Prot : SWS_FT_FI11

111) chain E
residue 110
type MOD_RES
sequence T
description Phosphothreonine => ECO:0007744|PubMed:24275569
source Swiss-Prot : SWS_FT_FI11

112) chain F
residue 110
type MOD_RES
sequence T
description Phosphothreonine => ECO:0007744|PubMed:24275569
source Swiss-Prot : SWS_FT_FI11

113) chain D
residue 138
type MOD_RES
sequence Y
description Phosphotyrosine => ECO:0007744|PubMed:19690332
source Swiss-Prot : SWS_FT_FI12

114) chain E
residue 138
type MOD_RES
sequence Y
description Phosphotyrosine => ECO:0007744|PubMed:19690332
source Swiss-Prot : SWS_FT_FI12

115) chain F
residue 138
type MOD_RES
sequence Y
description Phosphotyrosine => ECO:0007744|PubMed:19690332
source Swiss-Prot : SWS_FT_FI12

116) chain D
residue 21
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate => ECO:0000250|UniProtKB:P62157
source Swiss-Prot : SWS_FT_FI13

117) chain E
residue 21
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate => ECO:0000250|UniProtKB:P62157
source Swiss-Prot : SWS_FT_FI13

118) chain F
residue 21
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate => ECO:0000250|UniProtKB:P62157
source Swiss-Prot : SWS_FT_FI13

119) chain D
residue 93
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

120) chain D
residue 140
type BINDING
sequence E
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

121) chain E
residue 93
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

122) chain E
residue 95
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

123) chain E
residue 97
type BINDING
sequence N
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

124) chain E
residue 99
type BINDING
sequence Y
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

125) chain E
residue 104
type BINDING
sequence E
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

126) chain E
residue 129
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

127) chain E
residue 131
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

128) chain E
residue 133
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

129) chain E
residue 135
type BINDING
sequence Q
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

130) chain D
residue 95
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

131) chain E
residue 140
type BINDING
sequence E
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

132) chain F
residue 93
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

133) chain F
residue 95
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

134) chain F
residue 97
type BINDING
sequence N
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

135) chain F
residue 99
type BINDING
sequence Y
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

136) chain F
residue 104
type BINDING
sequence E
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

137) chain F
residue 129
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

138) chain F
residue 131
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

139) chain F
residue 133
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

140) chain F
residue 135
type BINDING
sequence Q
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

141) chain D
residue 97
type BINDING
sequence N
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

142) chain F
residue 140
type BINDING
sequence E
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

143) chain D
residue 99
type BINDING
sequence Y
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

144) chain D
residue 104
type BINDING
sequence E
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

145) chain D
residue 129
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

146) chain D
residue 131
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

147) chain D
residue 133
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

148) chain D
residue 135
type BINDING
sequence Q
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00448, ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03
source Swiss-Prot : SWS_FT_FI2

149) chain D
residue 115
type MOD_RES
sequence K
description N6-methyllysine; alternate => ECO:0007744|PubMed:24129315
source Swiss-Prot : SWS_FT_FI4

150) chain E
residue 115
type MOD_RES
sequence K
description N6-methyllysine; alternate => ECO:0007744|PubMed:24129315
source Swiss-Prot : SWS_FT_FI4

151) chain F
residue 115
type MOD_RES
sequence K
description N6-methyllysine; alternate => ECO:0007744|PubMed:24129315
source Swiss-Prot : SWS_FT_FI4

152) chain D
residue 21
type MOD_RES
sequence K
description N6-acetyllysine; alternate => ECO:0007744|PubMed:19608861
source Swiss-Prot : SWS_FT_FI5

153) chain E
residue 21
type MOD_RES
sequence K
description N6-acetyllysine; alternate => ECO:0007744|PubMed:19608861
source Swiss-Prot : SWS_FT_FI5

154) chain F
residue 21
type MOD_RES
sequence K
description N6-acetyllysine; alternate => ECO:0007744|PubMed:19608861
source Swiss-Prot : SWS_FT_FI5

155) chain D
residue 44
type MOD_RES
sequence T
description Phosphothreonine; by CaMK4 => ECO:0000250|UniProtKB:P0DP29
source Swiss-Prot : SWS_FT_FI6

156) chain E
residue 44
type MOD_RES
sequence T
description Phosphothreonine; by CaMK4 => ECO:0000250|UniProtKB:P0DP29
source Swiss-Prot : SWS_FT_FI6

157) chain F
residue 44
type MOD_RES
sequence T
description Phosphothreonine; by CaMK4 => ECO:0000250|UniProtKB:P0DP29
source Swiss-Prot : SWS_FT_FI6

158) chain D
residue 81
type MOD_RES
sequence S
description Phosphoserine => ECO:0007744|PubMed:23186163
source Swiss-Prot : SWS_FT_FI7

159) chain E
residue 81
type MOD_RES
sequence S
description Phosphoserine => ECO:0007744|PubMed:23186163
source Swiss-Prot : SWS_FT_FI7

160) chain F
residue 81
type MOD_RES
sequence S
description Phosphoserine => ECO:0007744|PubMed:23186163
source Swiss-Prot : SWS_FT_FI7

161) chain D
residue 94
type MOD_RES
sequence K
description N6-acetyllysine => ECO:0007744|PubMed:19608861
source Swiss-Prot : SWS_FT_FI8

162) chain E
residue 94
type MOD_RES
sequence K
description N6-acetyllysine => ECO:0007744|PubMed:19608861
source Swiss-Prot : SWS_FT_FI8

163) chain F
residue 94
type MOD_RES
sequence K
description N6-acetyllysine => ECO:0007744|PubMed:19608861
source Swiss-Prot : SWS_FT_FI8

164) chain D
residue 99
type MOD_RES
sequence Y
description Phosphotyrosine => ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:19690332
source Swiss-Prot : SWS_FT_FI9

165) chain E
residue 99
type MOD_RES
sequence Y
description Phosphotyrosine => ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:19690332
source Swiss-Prot : SWS_FT_FI9

166) chain F
residue 99
type MOD_RES
sequence Y
description Phosphotyrosine => ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:19690332
source Swiss-Prot : SWS_FT_FI9


Display surface

Download
Links